CT7001: An orally bioavailable CDK7 inhibitor is a potential therapy for breast, small-cell lung and haematological cancersEdward K. Ainscow,Andrew Leishman,Elaine Sullivan,Bo Li,William Gallagher,Adam Peall,Kristopher Clark,Stuart Thomson,Simak Ali,Raoul C. Coombes,Ash BahlCANCER RESEARCH(2018)引用 6|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要